Vazobral

Roman name

Vasobral

The composition and the form of

1 tablet contains альфа-дигидроэргокри��тина nelfinavir 4 mg caffeine and 40 mg; blistere in 10 pcs. , in a box 3 blister.1 ml reception inside - �льфа-дигидроэргокрип тина nelfinavir 1 mg caffeine and 10 mg; Patients in the dark glass of 50 ml with pipetkoy 2 ml, in a box one bottle.

Indications

Cerebrovascular insufficiency (including as a result of cerebral atherosclerosis), remnants of the human cerebral circulation, declining mentally alert, memory on the most recent developments, the decline attention disorders orientation; preventive treatment for migraines; kohleowestibularnae disorders (dizziness, noise in the ears, hypoacousis) ishemicski genesis; Ménière disease; retinopathy (including diabetic and hypertension); Violations of peripheral arterial diseases (in particular, syndrome and disease Reynaud); chronic venous insufficiency.

Contraindications

Hypersensitivity to components of the preparation. The safety of the women had not been proved. Appointment vazobrala nursing mothers can reduce weight (molokoobrazovania).

Side-Effects

In rare cases, nausea, pain in epigastria (the abdomen, located directly beneath mud arches rib and the sternum). Itchy skin, rashes. The decline in blood pressure. Vazobral no longer gipotenzivnogo (reducing blood pressure) effects it is nominated patients with arterial hypertension (persistent increase in blood pressure) is not precluded by the need for a antigipertenziveh (negative blood pressure) products. If you are a vazobrala and antigipertenziveh drugs may develop arterial hypotonia (lowering blood pressure below normal), and passed.

Specific guidance

In appointing the drug to patients with arterial hypertension is not precluded by the need for a antigipertenziveh drugs.

Patient interaction

Together with the appointment of hypotensive drugs to the development of arterial hypotonia (until passed).

Overdosing

Currently, the cases of drug overdose Vazobral were reported.

Dosing and Administration

Assign to 1-2 tablets or 2-4 ml (1-2 pipettes), 2 times a day. The drug should be taken at the time of delivery, a small amount of water.

Storage conditions

List B. At room temperature

Shelf life

The registration

010,162 (ERP)

Of drugs

Combined product, which is due to the properties of its components. Of the vazobrala digidroergokriptin - digidrirovannoe derivative LPV Locks alpha] - and альфа2-адренорецептор ы gladkomyshechnykh cells, platelets. It has a stimulating effect on dofaminergicakie and serotoninergicakie receptors central nervous system. In applying the drug reduced Aggregation (bonding) count and erythrocyte reduced permeability of vascular wall improving blood circulation and the metabolism (metabolism) in the brain, ensuring greater stability brain tissue to hypoxia (lack of oxygen owing to the lack of oxygen supply or interfere with digestion).

Indications for use

Cerebrovascular insufficiency (mismatch between the need tissues brain of oxygen and delivery), including, Cerebral because (of the brain) atherosclerosis; remnants of the human cerebral circulation; decline mentally alert, memory on the most recent developments, the decline attention disorders orientation; preventive treatment for migraines; kohleowestibularnae disorders (dizziness, noise in the ears, hypoacousis) ishemicski genesis (developed as a result of insufficient blood snails inner ear); retinopathy (damage to the walls of the receptacles retina), in particular, diabetic (associated with high blood sugar) and the disease Reynaud (reduced clearance receptacles limbs); chronic venous insufficiency.

Form of

Pill; Solution for the reception inside the vial with a pipette, annex 2 ml. 1 tablet contains : альфадигидроэргокрип тина - 2 mg, caffeine 20 mg. 2 ml contain : альфадигидроэргокрип тина - 2 mg, caffeine 20 mg.

Directory → Organotropona funds → Cardiovascular funds → Corrector disturbance of cerebral circulation → Vazobral